Ann: Chairman's Address to Shareholders, page-53

We all know his. It's just stating that at the end of the trial we will report all outcomes.

What needs urgent clarification are the conditions for releasing efficacy data in months which is consistent with their Q4 statement.

Get the feeling everyone can't wait to get out of the stock now as a result of today's AGM address. It was a pathetic address but I need answers. I am very disappointed no-one from here attended or bothered to post.